Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Rumberger

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Protocols|March 8, 2021
Modeling Skin Inflammation Using Human In Vitro ModelsErika Boarder, Beth Rumberger, Michael D Howell
JID Innovations : Skin Science From Molecules to Population Health|October 16, 2023
Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib CreamMichael D Howell, Fiona I Kuo, Beth Rumberger, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 12, 2017
INCB040093 Is a Novel PI3K<i>δ</i> Inhibitor for the Treatment of B Cell Lymphoid MalignanciesNiu Shin, Yun-Long Li, Song Mei, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Protocols|March 8, 2021
Modeling Skin Inflammation Using Human In Vitro ModelsErika Boarder, Beth Rumberger, Michael D Howell
JID Innovations : Skin Science From Molecules to Population Health|October 16, 2023
Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib CreamMichael D Howell, Fiona I Kuo, Beth Rumberger, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 12, 2017
INCB040093 Is a Novel PI3K<i>δ</i> Inhibitor for the Treatment of B Cell Lymphoid MalignanciesNiu Shin, Yun-Long Li, Song Mei, et al.
Pageof 1